Partially-Latent Class Models (pLCM) for Case-Control Studies of Childhood Pneumonia Etiology by Wu, Zhenke et al.
Johns Hopkins University, Dept. of Biostatistics Working Papers
5-31-2014
Partially-Latent Class Models (pLCM) for Case-
Control Studies of Childhood Pneumonia Etiology
Zhenke Wu
Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, zhwu@jhu.edu
Maria Deloria-Knoll
Department of International Health, Johns Hopkins Bloomberg School of Public Health, mknoll2@jhu.edu
Laura L. Hammitt
Department of International Health, Johns Hopkins Bloomberg School of Public Health, lhammitt@jhu.edu
Scott L. Zeger
Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health, sz@jhu.edu
This working paper is hosted by The Berkeley Electronic Press (bepress) and may not be commercially reproduced without the permission of the
copyright holder.
Copyright © 2011 by the authors
Suggested Citation
Wu, Zhenke; Deloria-Knoll, Maria; Hammitt, Laura L.; and Zeger, Scott L., "Partially-Latent Class Models (pLCM) for Case-Control
Studies of Childhood Pneumonia Etiology" (May 2014). Johns Hopkins University, Dept. of Biostatistics Working Papers. Working Paper
267.
http://biostats.bepress.com/jhubiostat/paper267
Partially-Latent Class Models (pLCM) for
Case-Control Studies of Childhood Pneumonia Etiology
Zhenke Wu∗1, Maria Deloria-Knoll2, Laura L. Hammitt2, Scott L. Zeger1
for the PERCH Core Team
1Department of Biostatistics, Johns Hopkins Bloomberg School of Public Health
2Department of International Health, Johns Hopkins Bloomberg School of Public Health
May 31, 2014
Abstract
In population studies on the etiology of disease, one goal is the estimation of the
fraction of cases attributable to each of several causes. For example, pneumonia is
a clinical diagnosis of lung infection that may be caused by viral, bacterial, fungal,
or other pathogens. The study of pneumonia etiology is challenging because directly
sampling from the lung to identify the etiologic pathogen is not standard clinical
practice in most settings. Instead, measurements from multiple peripheral specimens
are made. This paper considers the problem of estimating the population etiology dis-
tributionand the individual etiology probabilities. We formulate the scientific problem
in statistical terms as estimating the posterior distribution of mixing weights and
latent class indicators under a partially-latent class model (pLCM) that combines
∗Email: zhwu@jhu.edu
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heterogeneous measurements with different error rates obtained from a case-control
study. We introduce the pLCM as an extension of the latent class model. We also
introduce graphical displays of the population data and inferred latent-class frequen-
cies. The methods are illustrated with simulated and real data sets. The paper closes
with a brief description of extensions of the pLCM to the regression setting and to
the case where conditional independence among the measures is relaxed.
Keywords: Bayesian method; Case-control; Etiology; Latent class; Measurement
error; Pneumonia
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1 Introduction
Identifying the pathogens responsible for infectious diseases in a population poses signifi-
cant statistical challenges. Consider the measurement problem in the Pneumonia Etiology
Research for Child Health (PERCH), a case-control study that has enrolled 9, 500 children
from 7 sites around the world. Pneumonia is a clinical syndrome that develops because of
an infection of the lung tissue by bacteria, viruses, mycobacteria or fungi (Levine et al.,
2012). The appropriate treatment and public health control measures vary by pathogen.
Which pathogen is infecting the lung usually cannot be directly observed and must there-
fore be inferred from multiple peripheral measurements with differing error rates. The
primary goals of the PERCH study are to integrate the multiple sources of data to: (1)
aid the attribution of which pathogen or pathogens have caused a particular case’s lung
infection, and (2) estimate the prevalences of the etiologic pathogens in a population of
children.
The basic statistical framework of the problem is pictured in Figure 1. Let Yi represent
whether the child is a pneumonia case (Yi = 1) or control (Yi = 0). For a child with
pneumonia, let ILi indicate which pathogen causes the lung infection. I
L
i takes values in
{0, 1, 2, ...J} where 0 represents no infection (control) and ILi = j, j = 1, ..., J , represents the
jth pathogen from a pre-specified cause-of-pneumonia or pneumonia etiology list. Among
the J candidate pathogens being tested, we assume only one is the primary cause. Because,
for most cases, it is not possible to directly sample the lung, we do not know with certainty
which pathogen infected the lung, so we seek to infer the infection status ILi based upon a
series of laboratory measurements of specimens from various body fluids and body sources
S (MSi ).
The measurement error rates differ by type of measurement. In the motivating PERCH
application and the following discussions, the error rates refer to epidemiologic error rates
1
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that characterize the probability of the pathogen’s presence/absence in specimen tests given
whether it infected the lung. For this and possibly other applications, it is convenient to
categorize measures into three subgroups referred to as “gold”, “silver”, and “bronze”
standard measurements. A gold-standard (GS) measurement is assumed to have both
perfect sensitivity and specificity. A silver-standard (SS) measurement is assumed to have
perfect specificity, but imperfect sensitivity. Culturing bacteria from blood samples (B-
Cx) is an example of silver standard measurements in PERCH. Finally, bronze-standard
(BrS) measurements are assumed to have imperfect sensitivity and specificity. Polymerase
chain reaction (PCR) evaluation of bacteria and viruses from nasopharyngeal samples is an
example. In the PERCH study, both SS and BrS measurements are available in all cases.
BrS measures are also available for controls. A goal of this study is to develop a statistical
model that combines GS and SS measurements from cases, with bronze data from cases and
controls to estimate the distribution of pathogens in the population of pneumonia cases,
and the conditional probability that each of the J pathogens is the primary cause of an
individual child’s pneumonia given her or his set of measurements. Even in applications
where GS data is not available, a flexible modeling framework that can accommodate GS
data is useful for both the evaluation of statistical information from BrS data (Section
3) and the incorporation of GS data if it becomes available as measurement technology
improves.
Latent class models (LCM) (Goodman, 1974) have been successfully used to integrate
multiple diagnostic tests or raters’ assessments to estimate a binary latent status D ∈ {0, 1}
for all study subjects (Hui and Walter, 1980; Qu and Hadgu, 1998; Albert et al., 2001; Al-
bert and Dodd, 2008). (In these applications, D = 1 if IL > 0.) In the LCM framework,
conditional distributions [M |D = j], j = 0, 1, are specified to use multivariate measure-
ments M to maximize the likelihood as a function of the disease prevalence, sensitivities
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and specificities. This framework has also been extended to infer ordinal latent status
(Wang et al., 2011).
There are three salient features of the PERCH childhood pneumonia problem that
require extension of the typical LCM approach. First, we have partial knowledge of the
latent lung state IL for some subjects as a result of the case-control design. In the standard
LCM approach, the study population comprises subjects with completely unknown class
membership D. In this study, the latent etiology IL = 0 is applied to all controls because
absent clinical disease, the lung is assumed to be non-infected. Also, were gold standard
measurements available from the lung for some cases, their latent variable would be directly
observed. As the latent state is known for a non-trivial subset of the study population, we
refer to the model posited below as a partially-Latent Class Model or pLCM.
Second, in most LCM applications, the number of diagnostic test results on a subject
is much larger than the number of latent state categories. Here, the number of diagnostic
tests is of the same order, and often equal to the number of categories that IL can assume.
For example, if we consider only the PERCH study BrS data, we simultaneously observe
the presence/absence of J pathogens for each child. Even with additional control data, the
larger number of latent categories of IL leads to weak model identifiability as is discussed
in more detail in Section 2.1.
Lastly, measurements with differing error rates (i.e. GS, SS, BrS) need to be integrated
in this application. Understanding the relative value of each level of measurements is
important to optimally invest resources into data collection (number of subjects, type of
samples) and laboratory assays. An important goal is therefore to estimate the relative
information from each type of measurements about the population and individual etiology
distributions. Albert and Dodd (2008) studied a model where some subjects are selected to
verify their latent status (i.e. collect from them GS measurements) with the probability of
3
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verification depending on the previous test results or completely at random. They showed
GS data can make model estimates more robust to model misspecifications. We quantify
how much GS data reduces the variance of model parameter estimates for design purposes.
Also, they considered binary latent status and did not have available control data. Another
related literature that uses both GS and BrS data is on verbal autopsy (VA) in the setting
where no complete vital registry system is established in the community (King and Lu,
2008). Quite similar to the goal of inferring pneumonia etiology from lab measurements,
the goal of VA is to infer the cause of death (ID) from a pre-specified list by asking close
family members questions about the presence/absence of K symptoms. King and Lu (2008)
proposed estimating the cause-of-death distribution in community P (ID = j), j = 1, ...J,
(similar to etiology) using data on K dichotomous symptoms and GS data from the hospital
where cause-of-death and symptoms are both recorded. However, their method involves
nonparametric estimation of J K-way probability contingency tables and therefore requires
a sizable sample of GS data, especially when the number of symptoms is large. In addition,
a key difference between VA and most infectious disease etiology studies is that the VA
studies are by definition case-only.
Another approach previously used with case and control data is to perform logistic
regression of case status Y on laboratory measurements M and then to calculate point
estimates of population attributable risks for each pathogen (Bruzzi et al., 1985; Black-
welder et al., 2012). This method does not account for imperfect laboratory measurements
and cannot use GS data if available. Also, zero prevalence is assigned to pathogens whose
estimated odds ratios are smaller than 1, without taking account of their statistical uncer-
tainty.
In this paper, we define and apply a partially-latent class model (pLCM) with condi-
tional independent assumptions to incorporate these three features: known infection status
4
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for controls, a large number of latent classes, and multiple types of measurements. We
use a hierarchical Bayesian formulation to estimate: (1) the population etiology distribution
or etiology fraction —the frequency with which each pathogen “causes” clinical pneumo-
nia in the case population. and (2) the individual etiology probabilities—the probabilities
that a case is “caused” by each of the candidate pathogens, given observed specimen mea-
surements for that individual. Shrinkage of the individual’s predictive distribution toward
the population etiology distribution is controlled in a natural way by the estimated case
pathogen prevalences, and the differences in the estimated true positive rates relative to
false positive rates (Section 3); and (3) the relative information content of GS, SS, and BrS
data (Section 3 and 4).
The remainder of this paper proceeds as follows. In section 2, we formulate the pLCM
and the Gibbs sampling algorithms for implementation. In Section 3, we evaluate our
method through simulations tailored for the childhood pneumonia application. Section
4 presents the application of our methodology to a subsample of the PERCH data to
demonstrate its applicability. Lastly, Section 5 concludes with a discussion of results and
limitations, a few natural extensions of the pLCM also motivated by the PERCH data, as
well as future directions of research.
2 A partially-latent class model for multiple indirect
measurements
We develop pLCM to address two characteristics of the motivating pneumonia problem: (1)
a partially-latent state variable because the pathogen infection status is known for controls
but not cases; and (2) multiple categories of measurements with different error rates across
classes. As shown in Figure 1, let ILi , taking values in {0, 1, 2, ...J}, represent the true state
5
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of child i’s lung (i = 1, ..., N) where 0 represents no infection (control) and ILi = j, j =
1, ..., J , represents the jth pathogen from a pre-specified cause-of-pneumonia list that is
assumed to be exhaustive. Let MSi represent the J × 1 vector of binary indicators of the
presence/absence of each pathogen in the measurement at site S, where, in our application
S can be nasopharyngeal (NP), blood (B), or lung (L). Let mSi be the actual observed
values. In the following, we replace S with BrS, SS, or GS, because they correspond to the
measurement types at NP, B, and L, respectively.
Let Yi = yi ∈ {0, 1} represent the indicator of whether child i is a control or case. Note
ILi = 0 given Yi = 0. To formalize the pLCM, we define three sets of parameters:
• pi = (pi1, ..., piJ)T for the probability Pr(IL = j | Y = 1,pi), j = 1, ..., J
• ψSj = Pr(MSj = 1|IL = 0), the marginal false positive rate (FPR) for measurement j
at site S
• θSj = Pr(MSj = 1|IL = j), the marginal true positive rate (TPR) for measurement j
at site S for a person whose lung is infected by pathogen j.
We further let ψS = (ψS1 , ..., ψ
S
J )
T and θS = (θS1 , ..., θ
S
J )
T . Using these definitions, we have
FPR ψBrSj = 0 and TPR θ
BrS
j = 1 for GS measurements, so that M
GS
j = 1 if and only if
ILi = j (perfect sensitivity and specificity). Let δi be the binary indicator of a case i having
GS measurements; it equals 1 if the case has available GS data and 0 otherwise. For SS
measurements, FPR ψSSj = 0 so that M
SS
j = 0 if I
L
i 6= j (perfect specificity).
We formalize the model likelihood for each type of measurement. We first describe the
model for BrS measurement MBrS for a control or a case. For control i, positive detection
of the jth pathogen is a false positive representation of the non-infected lung. Therefore,
we assume MBrSij | ψBrS ∼ Bernoulli(ψSj ), j = 1, ..., J , with conditional independence, or
6
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equivalently,
P 0,BrSi = Pr(M
BrS
i = m | ψBrS ) =
J∏
j=1
(
ψBrSj
)mj (
1− ψBrSj
)1−mj
,m = mBrSi .(2.1)
For a case infected by pathogen j, the positive detection rate for the jth pathogen in BrS
assays is θBrSj . Since we assume a single cause for each case, detection of pathogens other
than j will be false positives with probability equal to marginal FPR as in controls: ψBrSl ,
l 6= j. This nondifferential misclassification across the case and control populations is the
essential assumption of the latent class approach because it allows us to borrow information
from control BrS data to distinguish the true cause from background colonization. We
further discuss it in the context of the pneumonia etiology problem in the final section.
Then,
P 1,BrSi′ = Pr(M
BrS
i′ = m | pi,θBrS ,ψBrS )
=
J∑
j=1
pij ·
(
θBrSj
)mj (
1− θBrSj
)1−mj∏
l 6=j
(
ψBrSl
)ml (
1− ψBrSl
)1−ml
,m = mBrSi′ (2.2)
is the likelihood contributed by BrS measurements from case i′. Convenient for Gibbs
sampler, we introduce the latent lung infection state ILi′ and represent (2.2) by the following
two-stage sampling scheme:
(i) multinomial sampling of lung infection state among cases: ILi′ | pi, Yi′ = 1 ∼ Multinomial(pi),
(ii) measurement stage given lung infection state:
MBrSi′j | ILi′ ,θBrS ,ψBrS ∼ Bernoulli
(
1{IL
i′=j}θ
BrS
j +
(
1− 1{IL
i′=j}
)
ψBrSj
)
, j = 1, ..., J ,
conditionally independent, where 1{·} is the indicator function and equals one if the
statement in {·} is true; otherwise, zero.
Similarly, likelihood contribution from a case i′’s SS measurements can be written as
P 1,SSi′ = Pr(M
SS
i′ = m | pi,θSS ) =
J ′∑
j=1
pij ·
(
θSSj
)mj
(1− θSSj )1−mj1{∑J′l=1ml≤1}, (2.3)
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for m = mSSi′ , noting the perfect specificity of SS measurements, where J
′ ≤ J represents
the number of actual SS measurements on each case, and θSS =
(
θSS1 , ...θ
SS
J ′
)
. SS mea-
surements only test for a subset of all J pathogens, e.g., blood culture only detects bacteria
and J ′ is the number of bacteria that are potential causes. Finally, GS measurement MGSi′
that accurately indicates the actual cause for case i′, is assumed to follow multinomial
distribution with likelihood:
P 1,GSi′ = Pr
(
MGSi′ = m | pi
)
=
J∏
j=1
pi
1{mj=1}
j 1{
∑
j mj=1},m = m
GS
i′ . (2.4)
Combining likelihood components (2.1)—(2.4), the total model likelihood for BrS, SS,
and GS data across independent cases and controls is
L(γ;D) =
∏
i:Yi=0
P 0,BrSi
∏
i′:Yi′=1,δi′=1
P 1,BrSi′ · P 1,SSi′ · P 1,GSi′
∏
i′′:Yi′′=1,δi′′=0
P 1,BrSi′′ · P 1,SSi′′ ,(2.5)
where γ = (θBrS ,ψBrS ,θSS ,pi)T stacks all unknown parameters, andD =
{{
mBrSi
}
i:Yi=1
}
∪{{
mBrSi′ ,m
GS
i′ ,m
SS
i′
}
i′:Yi′=1,δi′=1
}
∪
{{
mBrS
i′′ ,m
SS
i′′
}
i′′ :Y
i
′′=1,δ
i
′′=0
}
collects all the avail-
able measurements on study subjects. Our primary statistical goal is to estimate the
posterior distribution of the population etiology distribution pi, and obtain individual
etiology (IL∗ ) prediction given a case’s measurements (m
BrS
∗ ,m
SS
∗ ), i.e., Pr(I
L
∗ = j |
mBrS∗ ,m
SS
∗ ,D), j = 1, ..., J .
To enable Bayesian inference, prior distributions on model parameters are specified
as follows: pi ∼ Dirichlet(a1, . . . , aJ), ψBrSj ∼ Beta(b1j, b2j), θBrSj ∼ Beta(c1j, c2j), j =
1, ..., J , and θSSj ∼ Beta(d1j, d2j), j = 1, ..., J ′. Hyperparameters for etiology prior,
a1, ..., aJ , are usually 1s to denote equal and non-informative prior weights for each pathogen
if expert prior knowledge is unavailable. The FPR for the jth pathogen, ψBrSj , generally
can be well estimated from control data, thus b1j = b2j = 1 is the default choice. For TPR
parameters θBrSj and θ
SS
j , if prior knowledge on TPRs is available, we choose (c1j, c2j) so
8
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that the 2.5% and 97.5% quantiles of Beta distribution with parameter (c1j, c2j) match the
prior minimum and maximum TPR values elicited from pneumonia experts . Otherwise, we
use default value 1s for the Beta hyperparameters. Similarly we choose values of (d1j, d2j)
either by prior knowledge or default values of 1. We finally assume prior independence
of the parameters as [γ] = [pi][ψBrS ][θBrS ][θSS ], where [A] represents the distribution
of random variable or vector A. These priors represent a balance between explicit prior
knowledge about measurement error rates and the desire to be as objective as possible for
a particular study. As described in the next section, the identifiability constraints on the
pLCM require specifying a reasonable subset of parameter values to identify parameters of
greatest scientific interest.
2.1 Model identifiability
Potential non-identifiability of LCM parameters is well-known. For example, an LCM with
four observed binary indicators and three latent classes is not identifiable despite provid-
ing 15 degree-of-freedom to estimate 14 parameters (Goodman, 1974). In principle, the
Bayesian framework avoids the non-identifiability problem in LCMs by incorporating prior
information about unidentified parameter subspaces (Garrett and Zeger, 2000). Many au-
thors point out that the posterior variance for non-identifiable parameters does not decrease
to zero as sample size approaches infinity (e.g., Kadane (1974); Gustafson et al. (2001);
Gustafson (2005)). For scientific investigations, when data are not fully informative about
a parameter, an identified set of parameter values consistent with the observed data shall,
nevertheless, be valuable in a complex application (Gustafson, 2009) like PERCH.
This identifiability issue for the pLCM only occurs in the absence of GS data. Here we
restrict attention to the scenario with only BrS data for simplicity but similar arguments
pertain to the BrS + SS scenario. The problem can be understood from the form of the
9
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marginal positive measurement rates for pathogens among cases. In the pLCM likelihood
for BrS data (only retaining components in (2.5) with superscripts BrS ), the marginal
positive rate for pathogen j is a convex combination of the TPR and FPR:
Pr
(
MBrSi′j = 1 | pij, θBrSj , ψBrSj
)
= pijθ
BrS
j + (1− pij)ψBrSj , (2.6)
where the left-hand side of the above equation can be estimated by the observed marginal
positive rate of pathogen j among cases. Although the control data provide ψBrSj esti-
mates, the two parameters, pij and θ
BrS
j , are not both identified. GS data, if available,
identifies pij and resolves the lack of identifiability. Otherwise, we need to incorporate prior
scientific information on one of them, usually the TPR (θBrSj ), derived from infectious
disease and laboratory experts (Murdoch et al., 2012) and/or from vaccine probe studies
(Feikin et al., 2014). If the observed case marginal positive rate is much higher than the
rate in controls (ψBrSj ), only large values of TPR (θ
BrS
j ) are supported by the data making
etiology estimation more precise (Section 2.2).
In more generality, the full model identification can be characterized by inspecting the
Jacobian matrix of the transformation (F ) from model parameters (γ) to the distribution
of the observables (p): p = F (γ). Let γ = (θBrS ,ψBrS , pi1, ..., piJ−1)T represent the
3J−1-dimensional unconstrained model parameters. The pLCM defines the transformation
(p1,p0)
T = F (γ), where p1 and p0 are the two contingency probability distributions for the
BrS measurements in the case and control populations. It can be shown that the Jacobian
matrix Γ(γ) has J−1 of its singular values being zero, which means model parameters γ are
not fully identified from the data. The FPRs (ψBrSj , j = 1, ..., J) in pLCM are, however,
identifiable parameters that can be estimated from control data. Therefore, pLCM is
termed partially identifiable (Jones et al., 2010).
10
http://biostats.bepress.com/jhubiostat/paper267
2.2 Parameter estimation and individual etiology prediction
The parameters in likelihood (2.5) include the population etiology distribution (pi), TPRs
and FPRs for BrS measurements (ψBrS and θBrS ), and TPRs for SS measurements (θSS ).
The posterior distribution of these parameters can be estimated by constructing approxi-
mating samples from the joint posterior via Gibbs sampler. The full conditional distribu-
tions for the Gibbs sampler are detailed in Section 1 of the supplementary material.
We use freely available software WinBUGS 1.4, to fit the partially-latent class model.
Convergence was monitored via Markov chain Monte Carlo (MCMC) chain histories, auto-
correlations, kernel density plots, and Brooks-Gelman-Rubin statistics (Brooks and Gel-
man, 1998). The statistical results below are based on 10, 000 iterations of burn-in followed
by 10, 000 production samples from each of three parallel chains.
The Bayesian framework naturally allows individual within-sample classification (in-
fection diagnosis) and out-of-sample prediction. This section describes how we calculate
the etiology probabilities for an individual with measurements m∗. We focus on the more
challenging inference scenario when only BrS data are available; the general case follows
directly.
The within-sample classification for case i′ is based on the posterior distribution of
latent indicators given the observed data, i.e. Pr(ILi′ = j | D), j = 1, ..., J , which can be
obtained by averaging along the cause indicator (ILi′ ) chain from MCMC samples. For a
case with new BrS measurements m∗, we have
Pr(ILi′ = j |m∗,D) =
∫
Pr(ILi′ = j |m∗,γ) Pr(γ |m∗,D)dγ, j = 1, ...J, (2.7)
where the second factor in the integrand can be approximated by the posterior distribution
given current data, i.e., Pr(γ | D). For the first term in the integrand, we explicitly ob-
tain the model-based, one-sample conditional posterior distribution, Pr(ILi′ = j |m∗,γ) =
11
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pij`j(m∗;γ)
/∑
m pirm`m(m∗;γ), j = 1, ..., J , where `m(m∗;γ) =
(
θBrSj
)m∗j (
1− θBrSj
)1−m∗j∏
l 6=j
(
ψBrSl
)m∗l (
1− ψBrSl
)1−m∗l
is the mth mixture component likelihood function evaluated at m∗. The log relative prob-
ability of ILi = j versus I
L
i = l is
Rjl = log
(
pij
pil
)
+log

(
θBrSj
ψBrSj
)m∗j (
1− θBrSj
1− ψBrSj
)1−m∗j+log

(
ψBrSl
θBrSl
)m∗l (
1− ψBrSl
1− θBrSl
)1−m∗l .
The form of Rjl informs us about what is required for correct diagnosis of an individual.
Suppose ILi = j, then averaging over m∗, we have E[Rjl] = log (pij/pil) + I(θ
BrS
j ;ψ
BrS
j ) +
I(ψBrSl ; θ
BrS
l ), where I(v1, v2) = v1 log(v1/v2) + (1 − v1) log ((1− v1)/(1− v2)) is the in-
formation divergence (Kullback, 2012) that represents the expected amount of information
in m∗j ∼ Bernoulli(v1) for discriminating against m∗j ∼ Bernoulli(v2). If v1 = v2, then
I(v1; v2) = 0. The form of E[Rjl] shows that there is only additional information from BrS
data about an individual’s etiology in the person’s data when there is a difference between
θBrSj and ψ
BrS
j , j = 1, ..., J .
Following (2.7), we average Pr(ILi′ = j |m∗,γ) over MCMC iterations with γ replaced
by its similated values γ)∗ at each iteration. Repeating for j = 1, ..., J , we obtain a J
probability vector, pi′ = (pi′1, ..., pi′J)
T , that sums to one. This scheme is especially useful
when a newly examined case has a BrS measurement pattern not observed in D, which often
occurs when J is large. The final decisions regarding which pathogen to treat can then be
based upon estimated p̂i′ . In particular, the pathogen with largest posterior value might
be selected. It is Bayes optimal under mean misclassification loss. Individual etiology
predictions described here generalize the positive/negative predictive value (PPV/NPV)
from single to multivariate binary measurements and can aid diagnosis of case subjects
under other user-specified misclassification loss functions.
12
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3 Simulation for three pathogens case with GS and
BrS data
One key question for studies like PERCH is what fraction of the total evidence about
etiology derives from the BrS sources relative to from GS or SS sources if available. In
this simulation, we illustrate the extent to which BrS case-control data can supplement
observation of the etiologic agent directly from the site of infection. We discuss the role of
SS measurements in Section 4 through application to the PERCH data set.
We simulate BrS data sets with 500 cases and 500 controls for three pathogens, A, B,
and C using pLCM specifications. We focus on three states to facilitate viewing of the pi
estimates and individual predictions in the 3-dimensional simplex S2. We use the ternary
diagram (Aitchison, 1986) representation where the vector pi = (piA, piB, piC)
T is encoded
as a point with each component being the perpendicular distance to one of the three sides.
The parameters involved are fixed at TPR = θ = (θA, θB, θC)
T = (0.9, 0.9, 0.9)T , FPR =
ψ = (ψA, ψB, ψC)
T = (0.6, 0.02, 0.05)T , and pi = (piA, piB, piC)
T = (0.67, 0.26, 0.07)T . We
focus on BrS and GS data here and drop the “BrS ” superscript on the parameters for
simplicity. We further let the fraction of cases with GS measurements (∆) be either 1%
or 10%. Although GS measurements are rare in the PERCH study, we investigate a large
range of ∆ to understand in general how much statistical information is contained in BrS
measurements relative to GS measurements.
For any given data set, three distinct subsets of the data can be used: BrS-only, GS-only,
and BrS+GS, each producing its posterior mean of pi, and 95% credible region (Bayesian
confidence region) by transformed Gaussian kernel density estimator for compositional
data (Chaco´n et al., 2011). To study the relative importance of the GS and BrS data, the
primary quantity of interest in the simulations is the relative sizes of the credible regions
13
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for each data mix. Here, we use uniform priors on θ, ψ, and Dirichlet(1, ..., 1) prior for pi.
The results are shown in Figure 2.
First, in Figures 2(a) (1% GS) and 2(b) (10% GS), each region covers the true etiology
pi. In data not shown here, the nominal 95% credible regions covers slightly more than 95%
of 100 simulations. Credible regions narrow in on the truth as we combine BrS and GS
data, and as the fraction of subjects with GS data (∆) increases. Also, the posterior mean
from the BrS+GS analysis is a result of optimal balance between information contained in
the GS and BrS data.
We then fix ψ and pi, while varying the TPR θ on the grid (0.6, 0.7, 0.8, 0.9, 0.95, 0.99)
to test the estimation performance under a variety of signal-to-noise ratios, measured by
the difference between the TPRs and FPRs. At each (θ, ∆) grid point, we run analyses
on each of 100 simulated data sets. We quantify the gain in precision by adding the
BrS data to the GS data following Xu and Zeger (2001). For pathogen A, let gA(θ) =(
d0A − dBrS +GSA (θ)
)
/
(
d0A − dGSA (θ)
)
, where d0A, d
GS
A (θ) and d
BrS +GS
A (θ) are the length
of 95% highest density interval from the prior, length of 95% credible interval using GS
data, and length of the 95% credible interval using BrS and GS data, respectively. This
quantity (gA(θ)) is the ratio of the reduction of the 95% interval widths with and without
the BrS data at TPR value θ. If gA(θ) = 1, then there is no additional gain in the
precision of piA when BrS data is added to GS data. When ∆ = 1%, we observe the
expected increase in gA as TPR θ approaches 1. For pathogen A, gA(0.8) has mean value
1.7 across 100 simulated data sets with standard error 0.3; gA(0.95) further increase to
3.0(standard error 0.3). Similar patterns are also observed for pathogen B and C.
Using the same simulated data sets, Figures 2(a) and 2(b) also show individual etiology
predictions for each of the 8(= 23) possible BrS measurements (mA,mB,mC)
T ,mj = 0, 1,
obtained by the methods from Section 2.2. Consider the example of a newly enrolled case
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without GS data and with no pathogen observed in her BrS data: m = (0, 0, 0). Suppose
she is part of a case population with 10% GS data. In the case illustrated in Figure 2(b),
her posterior predictive distribution has highest posterior probability (0.76) on pathogen A
reflecting two competing forces: the FPRs that describe background colonization (coloniza-
tion among the controls) and the population etiology distribution; Given other parameters,
m = (0, 0, 0) gives the smallest likelihood for ILi = A because of its high FPR that reflects
its background colonization rate, ψA = 0.6. However, prior to observing (0, 0, 0), piA is well
estimated to be much larger than piB and piC . Therefore the posterior distribution for this
case is heavily weighted towards pathogen A.
For a case with observation (1, 1, 1), because it is rare to observe pathogen B in a case
whose pneumonia is not caused by B, the prediction favors B. Although B is not the most
prevalent cause among cases, the presence of B in the BrS measurements gives the largest
likelihood when ILi = B. For any measurement pattern with a single positive, the case is
always classified into that category in this example.
Most predictions are stable with increasing ∆. Only 000 cases have predictions that
move from near the center to the corner of A. This is mainly because that TPR θ and
etiology fractions pi are not as precisely estimated in GS-scarce scenarios relative to GS-
abundant ones. Averaging over a wider range of θ and pi produces 000 case predictions
that are ambiguous, i.e. near the center. As ∆ increases, parameters are well estimated,
and precise predictions result.
4 Analysis of PERCH data
The Pneumonia Etiology Research for Child Health (PERCH) study is a standardized and
comprehensive evaluation of etiologic agents causing severe and very severe pneumonia
among hospitalized children aged 1-59 months in seven low and middle income countries.
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The study sites include countries with a significant burden of childhood pneumonia and a
range of epidemiologic characteristics (Levine et al., 2012). PERCH is a case-control study
that has enrolled over 4, 000 patients hospitalized for severe or very severe pneumonia and
over 5, 000 controls selected randomly from the community frequency-matched on age in
each month. More details about the PERCH design are available in Deloria-Knoll et al.
(2012).
To illustrate the application of pLCM model for the analysis of PERCH study data,
we have focused on preliminary data from one site with good availability of both SS and
BrS laboratory results. Results for all 7 countries will be reported elsewhere upon study
completion. Included in the current illustrative analysis are BrS data (nasopharyngeal
specimen with PCR detection of pathogens) for 432 cases and 479 frequency-matched
controls on 11 species of pathogens (7 viruses and 4 bacteria with their abbreviations in
Figure 3, and full names in Section 2 of the supplementary material), and SS data (blood
culture results) on the 4 bacteria for only the cases.
In PERCH, prior scientific knowledge of measurement error rates is incorporated into
the analysis. The TPR of our BrS measurements, θBrSj is assumed to be in the range of
90%− 97% (Murdoch et al., 2012). Observations from vaccine probe studies—randomized
clinical trials of pathogen-specific vaccines in which non-specific clinical endpoints such
as clinical pneumonia are evaluated thereby revealing the contribution of the pathogen
to the burden of that syndrome— illustrate that the total number of clinical pneumonia
cases prevented by the vaccine is much larger than the few laboratory-confirmed cases
prevented. Comparing the total preventable disease burden to the number of blood culture
(SS) positive cases prevented provides information about the TPR of the bacterial blood
culture measurements, θSSj , j = 1, ..., 4. In our analysis, we use the range 10 − 20% for
the SS TPRs of four bacteria. We set Beta priors that match these ranges (Section 2) and
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assumed Dirichlet(1, ..., 1) prior on etiology fractions pi.
In latent variable models like the pLCM, key variables are not directly observed. It is
therefore essential to picture the model inputs and outputs side-by-side to better under-
stand the analysis performed. In this spirit, Figure 3 displays for each of the 11 pathogens,
a summary of the BrS and SS data in the left two columns, along with some of the interme-
diate model results; and the prior and posterior distributions for the etiology fractions on
the right (rows ordered by posterior means). The observed BrS rates (with 95% confidence
intervals) for cases and controls are shown on the far left with solid dots. The conditional
odds ratio contrasting the case and control rates given the other pathogens is listed with
95% confidence interval in the box to the right of the BrS data summary. Below the case
and control observed rates is a horizontal line with a triangle. From left to right, the line
starts at the estimated false positive rate (FPR, ψ̂BrSj ) and ends at the estimated true pos-
itive rate (TPR, θ̂BrSj ), both obtained from the model. Below the TPR are two boxplots
summarizing its posterior (top) and prior (bottom) distributions for that pathogen. These
box plots show how the prior assumption influences the TPR estimate as expected given
the identifiability constraints discussed in Section 2.1. The triangle on the line is the model
estimate of the case rate to compare to the observed value above it. As discussed in Section
2.1, the model-based case rate is a linear combination of the FPR and TPR with mixing
fraction equal to the estimated etiology fraction. Therefore, the location of the triangle,
expressed as a fraction of the distance from the FPR to the TPR, is the model-based point
estimate of the etiologic fraction for each pathogen. The SS data are shown in a similar
fashion to the right of the BrS data. By definition, the FPR is 0.0 for SS measures and
there is no control data. The observed rate for the cases is shown with its 95% confidence
interval. The estimated SS TPR (θ̂SSj ) with prior and posterior distributions is shown as
for the BrS data, except that we plot 95% and 50% credible intervals for SS TPR above
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its prior distribution boxplot.
On the right side of the display are the marginal posterior and prior distributions of the
etiologic fraction for each pathogen. We appropriately normalized each density to match
the height of the prior and posterior curves. The posterior mean with 50% and 95% credible
intervals are shown above the density.
Figure 3 shows that respiratory syncytial virus (RSV), Streptococcus pneumoniae (PNEU),
rhinovirus (RHINO), and human metapneumovirus (HMPV A B) occupy the greatest frac-
tions of the etiology distribution, from 10% to 30% each. That RSV has the largest esti-
mated mean etiology fraction reflects the large discrepancy between case and control posi-
tive rates in the BrS data: 25.3% versus 0.8% (marginal odds ratio 38.5 (95%CI (18, 128.7)
) as shown on the left of the display. RHINO has marginal case and control rates that
are close to each other, yet its estimated mean etiology fraction is 15.9%. This is because
the model considers the joint distribution of the pathogens, not the marginal rates. The
conditional odds ratio of case status with RHINO given all the other pathogen measures is
estimated to be 1.5 (1.1, 2.1) as compared to the marginal odds ratio close to 1 (0.8, 1.3).
As discussed in Section 2.1, the data alone cannot precisely estimate both the etiologic
fractions and TPRs absent prior knowledge. This is evidenced by comparing the prior and
posterior distributions for the TPRs in the BrS boxes for each pathogen (i.e. left hand
column of Figure 3). The posteriors are similar to their priors indicating little else about
TPR is learned from the data. The posteriors for some pathogens making up pi (i.e. shown
in the right hand column of Figure 3) are likely to be sensitive to the prior specifications
of the TPRs.
We performed sensitivity analyses using multiple sets of priors for the TPRs. At one
extreme, we ignored background scientific knowledge and let the priors on the FPR and
TPR be uniform for both the BrS and SS data. The results are shown in Figure 7. Ignoring
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prior knowledge about error rates lowers the etiology estimates of the bacteria PNEU and
Haemophilus influenzae (HINF). The substantial reduction in the etiology fraction for
PNEU, for example, is a result of the difference in the TPR prior for the SS measurements.
In the original analysis (Figure 3), the informative prior on the SS sensitivity (TPR) place
95% mass between 10−20%. Hence the model assumes almost 85% of the PNEU infections
are being missed in the SS sampling. When a uniform prior is substituted (Figure 4), the
fraction assumed missed is greatly reduced. For RSV, its posterior mean etiology fraction
increases from 27.3% to 31.7%. The etiology estimates for other pathogens are fairly stable,
with changes in posterior means between −0.4% and 3.3%.
Under the original priors for TPR, PARA1 has an estimated etiologic fraction of 5.2%,
even though it has conditional odds ratio 5.8 (2.5, 15). In general, pathogens with larger
conditional odds ratios have larger etiology fraction estimates. Also, a pathogen still needs
a reasonably high observed case positive rate to be allocated a high etiology fraction. The
posterior etiology fraction estimate of 5.2% for PARA1 results because the prior for the
TPR takes values in the range of 0.9 − 0.97. By Equation (2.6), the TPR weight in the
convex combination with FPR (around 1.5%) has to be very small to explain the small
observed case rate 5.5%. When a uniform prior is placed on TPR instead, the PARA1
etiology fraction increases to 10.2% with a wider 95% credible interval (Figure 4).
Furthermore, when uniform priors on TPR and FPR are used, PARA1 is still allocated
a smaller etiology fraction than RHINO despite PARA1 having a larger conditional odds
ratio. This is related to the dependence structure among case measurements. RHINO
has the highest negative association with RSV among cases (standardized log odds ratio
−14). Under the conditional independence assumption of the pLCM, this dependence is
partly induced by multinomial correlation among the latent cause indicators: ILi = RSV
versus ILi = RHINO that is −piRSVpiRHINO. RSV has strong evidence as a frequent cause
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with a stable estimate piRSV around 30%. The strong negative association in the cases’
measurements between RHINO and RSV is contributing to the increased etiologic fraction
estimate piRHINO relative to other pathogens that have less or no association with RSV
among the cases. The conditional independence assumption is leveraging information from
the associations between pathogens in estimation of the etiologic fractions.
We have checked the model in two ways by comparing the characteristics of the observed
measurements joint distribution with the same characteristic for the distribution of new
measurements generated by the model from a population of the same size. By generating
the new data characteristics at every iteration of the MCMC chain, we can integrate the
predictive distribution over the posterior distribution of the parameters as discussed in
Garrett and Zeger (2000). Figure 5 displays the observed frequency of the 10 most common
measurement outcomes for the BrS data, separately for cases and controls to compare to
the predictive distributions based upon the model. Among the cases, the 95% predictive
interval includes the observed values in all but two of the BrS patterns and even there the fits
are reasonable. Among the controls, there is evidence of lack of fit for the most common BrS
pattern with only PNEU and HINF. There are fewer cases with this pattern observed than
predicted under the pLCM. This lack of fit is due to associations of pathogen measurements
in control subjects. Note that the FPR estimates remain consistent regardless of such
correlation as the number of controls increases, however posterior variances for them may
be underestimated.
Figure 6 presents standardized log odds ratios (SLORs) for cases (lower triangle) and
controls (upper triangle). Each entry is the observed log odds ratio for a pair of BrS
measurements minus the mean LOR for the predictive data distribution value divided by
the standard deviation of the LOR predictive distribution. The first significant digit of the
absolute SLOR is shown in blue for negative and red for positive values. Absolute SLORs
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less than 2 are omitted from the table for graphical effect. We see two large deviations
among the cases: RSV with RHINO and RSV with HMPV. These are caused by strong
seasonality in RSV that is out of phase with weaker seasonality in the other two. Otherwise,
the associations are roughly what is expected under the assumed model.
An attractive feature of using MCMC to estimate posterior distributions is the ease
of estimating posteriors for functions of the latent variables and/or parameters. One in-
teresting question from a clinical perspective is whether viruses or bacteria are the major
cause and among each subgroup, which species predominate. Figure 7 shows the poste-
rior distribution using expert TPR prior for viruses versus bacteria on the top, and then
the conditional distributions of the two leading bacteria (viruses) among bacterial (viral)
causes below. The posterior shape of the viral etiologic fraction is more concentrated com-
pared to the prior shape, with mode around 63% and 95% credible interval (54%, 71%).
Of all viral cases, RSV is estimated to cause about 43% (36%, 51%), and RHINO about
25% (17%, 34%). PNEU accounts for most bacterial cases (71% (48%, 87%)), and HINF
accounts for 19% (4%, 42%). In both the viral and bacterial categories, the 95% credible
intervals for the first most common pathogen does not overlap that of the second most
common one.
5 Discussion
In this paper, we estimated the frequency with which pathogens cause disease in a case
population using a partially-latent class model (pLCM) to allow for known states for a
subset of subjects and for multiple types of measurements with different error rates. In a
case-control study of disease etiology, measurement error will bias estimates from traditional
logistic regression and attributable fraction methods. The pLCM avoids this pitfall and
more naturally incorporates multiple sources of data. Here we considered three levels of
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measurement error rates.
Absent GS data, we show that the pLCM is only partially identified because of the
relationship between the estimated TPR and prevalence of the associated pathogen in the
population. Therefore, the inferences are sensitive to the assumptions about the TPR.
Uncertainty about their values persists in the final inferences from the pLCM regardless of
the number of subjects studied.
The current model provides a novel solution to the analytic problems raised by the
PERCH Study. This paper illustrates the design and application of the pLCM using a
preliminary and limited set of data from one PERCH study site. Confirmatory laboratory
testing, incorporation of additional pathogens, and adjustment for various factors are likely
to change the scientific findings that will be reported in the complete analysis of the study
results.
An essential assumption relied upon in the pLCM is that the probability of detecting
one pathogen at a peripheral body site depends on whether that pathogen is infecting the
child’s lung, but is unaffected by the presence of other pathogens in the lung, that is, the
non-differential misclassification error assumption, [MSSij | ILi = l] = [MSSij | ILi = k],
∀l, k 6= j. We have formulated the model to include GS measures even though they are
infrequently available from PERCH cases. In general, the availability of GS measures makes
it possible to test this assumption as has been discussed by Albert and Dodd (2008).
Several extensions have potential to improve the quality of inferences drawn and are
being developed for PERCH. First, because the control subjects have known class, we
can model the dependence structure among the BrS measurements and use this to avoid
aspects of the conditional independence assumption central to most LCM methods. The
approach is to extend the pLCM to have K subclasses within each of the current disease
classes. These subclasses can introduce correlation among the BrS measurements given
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the true disease state. An interesting question is about the bias-variance trade-off for
different values of K. This ideas follows previous work on the PARAFAC decomposition of
probability distribution for multivariate categorical data (Dunson and Xing, 2009). This
extension will enable model-based checking of the standard pLCM.
Second, in our analyses to date, we have assumed that the pneumonia case definition
is error-free. Given new biomarkers and availability of chest radiograph that can improve
upon the clinical diagnosis of pneumonia, one can introduce an additional latent variable
to indicate true disease status and use these measurements to probabilistically assign each
subject as a case or control. Finally, regression extensions of the pLCM will allow PERCH
investigators to study how the etiology distributions vary with HIV status, age group, and
season.
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A Full conditional distributions in Gibbs sampler
In this section, we provide analytic forms of full conditional distributions that are essential
for Gibbs sampling algorithm. We use data augmentation scheme by introducing latent lung
state ILi into the sampling chain and we have the following full conditional distributions:
• [ILi | others]. If MGSi is available, Pr (ILi = j | others) = 1, if MGSij = 1 and MGSil =
0, for l 6= j; otherwise zero. If MGSi is missing, according as whether MSSi is
available, the full conditional is given as
Pr(ILi = j | others) ∝(
θBrSj
)MBrSij (
1− θBrSj
)1−MBrSij ∏
l 6=j
(
ψBrSl
)MBrSil (
1− ψBrSl
)1−MBrSil
·
[(
θSSj
)MSSij
(1− θSSj )1−M
SS
ij 1{∑
l 6=jM
SS
il =0
}
]1{j≤J′}
· pij; (A.1)
if SS measurement is not available for case i, we remove terms involving MSSij .
•
[
ψBrSj | others
]
∼ Beta
(
Nj + b1j, n1 −
∑
i:Yi=1
1{ILi =j} + n0 −Nj + b2j
)
, where n1
and n0 are number of cases and controls, respectively, and Nj =
∑
i:Yi=1,ILi 6=jM
BrS
ij +∑
i:Yi=0
MBrSij is the number of positives at position j for cases with I
L
i 6= j and all
controls.
•
[
θBrSj | others
]
∼ Beta
(
Sj + c1j,
∑
i:Yi=1
1{ILi =j} − Sj + c2j
)
, where Sj =
∑
i:Yi=1,ILi =j
MBrSij
is the number of positives for cases with jth pathogen as their causes.
•
[
θSSj | others
]
∼ Beta
(
Tj + d1j,
∑
i:Yi=1,SS available 1{ILi =j} − Tj + d2j
)
, where
Tj =
∑
i:Yi=1,ILi =j,SS available
MSSij .
When no SS data is available, this conditional distribution reduces to Beta(d1j, d2j),
the prior.
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• [pi | ILi , i : Yi = 1] ∼ Dirichlet(a1 + U1, ..., aJ + UJ), where Uj = ∑i:Yi=1 1{ILi =j}.
B Pathogen names and their abbreviations
Bacteria: HINF- Haemophilus influenzae; PNEU-Streptococcus pneumoniae; SASP-Salmonella
species; SAUR-Staphylococcus aureus.
Viruses: ADENOVIRUS-adenovirus; COR 43-coronavirus OC43; FLU C-influenza virus
type C; HMPV A B-human metapneumovirus type A or B; PARA1-parainfluenza type 1
virus; RHINO-rhonovirus; RSV A B-respiratory syncytial virus type A or B.
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Figure 1: Directed acyclic graph (DAG) illustrating relationships among lung infection state
(IL), imperfect lab measurements on the presence/absence of each of a list of pathogens at
each site(MNP , MB and ML), disease outcome, and covariates (X). For a subject missing
one or more of the three types of measurements, we remove the corresponding measurement
component(s). For example, if a case does not have lung aspirate (LA) measurement, we
remove ML from the DAG.
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Figure 2: Population and individual etiology estimations for a single sample with 500 cases
and 500 controls with true pi = (0.67, 0.26, 0.07)T and either 1%N = 5) or 10%(N = 50)
GS data on cases. In (a) or (b), Red circled plus shows the true population etiology
distribution pi. The closed curves are 95 percent credible regions: blue dashed lines “- - -”,
light green solid lines “—”, black dotted lines “· · · ” correspond to analysis using BrS data
only, BrS+GS data, GS data only, respectively; Solid square/dot/triangle are corresponding
posterior means of pi; The 95 percent highest density region of uniform prior distribution
is also visualized by red “· − ·−” for comparison. 8(= 23) BrS measurement patterns
and predictions for individual children are shown with different shapes, with measurement
patterns attached to them. The radii of circles and numbers at the vertices show empirical
frequencies GS measurements belonging to A, B, or C.
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Figure 3: Results using expert priors on TPRs. The observed BrS rates (with 95% confidence intervals)
for cases and controls are shown on the far left. The conditional odds ratio given the other pathogens
is listed with 95% confidence interval in the box to the right of the BrS data summary. Below the case
and control observed rates is a horizontal line with a triangle. From left to right, the line starts at the
estimated false positive rate (FPR, ψ̂BrSj ) and ends at the estimated true positive rate (TPR, θ̂
BrS
j ),
both obtained from the model. Below the TPR are two boxplots summarizing its posterior (top) and prior
(bottom) distributions. The location of the triangle, expressed as a fraction of the distance from the FPR
to the TPR, is the model-based point estimate of the etiologic fraction for each pathogen. The SS data
are shown in a similar fashion to the right of the BrS data. The observed rate for the cases is shown with
its 95% confidence interval. The estimated SS TPR (θ̂SSj ) with prior and posterior distributions is shown
as for the BrS data, except that we plot 95% and 50% credible intervals for SS TPR above the boxplot for
its prior distribution. See Appendix for pathogen name abbreviations.
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Figure 4: Results on using uniform priors on TPRs. As in Figure 3 with uniform priors on
the TPRs.
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Figure 5: Posterior predictive checking for 10 most frequent BrS measurement patterns
among cases and controls with expert priors on TPRs.
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Figure 6: Posterior predictive checking for pairwise odds ratios separately for cases (lower
right triangle) and controls (upper left triangle) with expert priors on TPRs. Each entry
is a standardized log odds ratio (SLOR): the observed log odds ratio for a pair of BrS
measurements minus the mean LOR for the posterior predictive distribution divided by
the standard deviation of the posterior predictive distribution. The first significant digit of
absolute SLORs are shown in red for positive and blue for negative values, and only those
greater than 2 are shown. 34
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Figure 7: Summary of posterior distribution of pneumonia etiology estimates using expert
(left) and uniform (right) priors on TPRs. In each subfigure, top: posterior (solid) and
prior (dashed) distribution of viral etiology; bottom left: posterior etiology distribution
for top two bacterial causes given bacteria is a cause; bottom right: posterior etiology
distribution for top two viral causes given virus is a cause. B-rest and V-rest stand for the
rest of bacteria and viruses other than the top two species, respectively. The nested blue
circles are 95%, 80%, and 50% credible regions for population etiology estimates within
bacterial or viral group.
35
Hosted by The Berkeley Electronic Press
